Publications by authors named "Peter Lembessis"

Claim this Profile
T
The effect of prolonged intense physical exercise of special forces volunteers on their plasma protein denaturation profile examined by differential scanning calorimetry.
Stamatis Mourtakos, Anastassios Philippou, Anastasios Papageorgiou, Peter Lembessis, Stella Zaharinova

J Therm Biol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods of detection of circulating melanoma cells: a comparative overview.
Andrianos Nezos, Pavlos Msaouel, Nikolaos Pissimissis, Peter Lembessis, Antigone Sourla

Cancer Treat Rev· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of the circulating tumor cells in cancer patients.
Athanasios Armakolas, Zacharoula Panteleakou, Adrianos Nezos, Aikaterini Tsouma, Maria Skondra, Peter Lembessis

Future Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
Nea Pitulis, Efstathia Papageorgiou, Roxane Tenta, Peter Lembessis, Michael Koutsilieris

Anticancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of circulating tumor cells in bladder cancer patients.
Adrianos Nezos, Nikolaos Pissimisis, Peter Lembessis, Antigone Sourla, Peter Dimopoulos

Cancer Treat Rev· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance.
Zacharoula Panteleakou, Peter Lembessis, Antigone Sourla, Nikolaos Pissimissis, Aristides Polyzos

Mol Med· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance.
Adrianos Nezos, Peter Lembessis, Antigone Sourla, Nikolaos Pissimissis, Helen Gogas

Clin Chem Lab Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells.
Nikolaos Pissimissis, Efstathia Papageorgiou, Peter Lembessis, Athanasios Armakolas, Michael Koutsilieris

Anticancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The kisspeptin (KiSS-1)/GPR54 system in cancer biology.
Angeliki Makri, Nikolaos Pissimissis, Peter Lembessis, Constantine Polychronakos, Michael Koutsilieris

Cancer Treat Rev· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells.
Efstathia Papageorgiou, Nea Pitulis, Menelaos Manoussakis, Peter Lembessis, Michael Koutsilieris

Mol Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction.
Antonios Halapas, Achilleas Zacharoulis, Stamatios Theocharis, Apostolos Karavidas, Dimitrios Korres, Peter Lembessis

Clin Chem Lab Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy.
Peter Lembessis, Pavlos Msaouel, Antonis Halapas, Antigone Sourla, Zacharoula Panteleakou

Clin Chem Lab Med· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular myocardium of the Langendorff ischaemia-reperfusion model.
Antonios Halapas, Peter Lembessis, Iordanis Mourouzis, Costas Pantos, Dennis V Cokkinos

Exp Physiol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines.
Efstathia Papageorgiou, Nea Pitulis, Pavlos Msaouel, Peter Lembessis, Michael Koutsilieris

Expert Opin Ther Targets· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
Michael Koutsilieris, Theodore Dimopoulos, Constantine Milathianakis, John Bogdanos, Dimitrios Karamanolakis, Peter Lembessis

BJU Int· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristics.
Georgios Mitropapas, Andrianos Nezos, Antonis Halapas, Nikolaos Pissimissis, Peter Lembessis

Clin Chem Lab Med· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum testosterone: A potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (> or =3.0 and <10.0 ng/ml).
Dimitrios Karamanolakis, Theocharis Lambou, John Bogdanos, Constantine Milathianakis, Antigone Sourla, Peter Lembessis

Anticancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.
Michael Koutsilieris, John Bogdanos, Constantine Milathianakis, Peter Dimopoulos, Theodoros Dimopoulos, Peter Lembessis

Expert Opin Investig Drugs· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
Roxane Tenta, Antigone Sourla, Peter Lembessis, Michael Koutsilieris

Anticancer Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular staging using qualitative RT-PCR analysis detecting thyreoglobulin mRNA in the peripheral blood of patients with differentiated thyroid cancer after therapy.
Niki Karavitaki, Peter Lembessis, Marinela Tzanela, Varvara Vlassopoulou, Nicholaos Thalassinos

Anticancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular staging by RT-pCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer.
Constantine S Mitsiades, Peter Lembessis, Antigone Sourla, Constantine Milathianakis, Athanassios Tsintavis

Clin Exp Metastasis· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the glutametergic system in MG-63 osteoblast-like osteosarcoma cells.
Niki Kalariti, Peter Lembessis, Michael Koutsilieris

Anticancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid receptor function suppresses insulin-like growth factor 1 activity in human KLE endometrial-like cells.
Peter Lembessis, Niki Kalariti, Michael Koutsilieris

In Vivo· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapy.
Peter Karamanakos, Constantine S Mitsiades, Peter Lembessis, Michael Kontos, Demetrios Trafalis

Anticancer Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells.
Roxane Tenta, Despina Tiblalexi, Evangelia Sotiriou, Peter Lembessis, Menelaos Manoussakis

Prostate· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis